Injectable Gelled Multiple Emulsion for Glucose‐Responsive Insulin Delivery
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202304195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Kofi Oti Boakye-Yiadom und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shang…. Hauptthemen laut MEDLINE: Emulsions, Insulin, Blood Glucose, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: The Natural Science Foundation of Shanghai, The National Natural Science Foundation of China.
Abstract (Originalsprache)
A glucose‐responsive insulin delivery system that sustains blood glucose equilibrium for an extended duration can address the low therapeutic window of insulin in diabetes treatment. Herein, insulin is loaded in a water‐in‐oil‐in‐water (W 1 /O/W 2 ) gelled multiple emulsion using poly (4‐vinylphenylboronic acid) (PVPBA) homopolymer as an effective emulsifier. The gelled multiple emulsion exhibits a high encapsulation efficiency (99%), enhanced stability and remarkable shear‐thinning behavior, making it easy to inject. Under hyperglycemic conditions, the gelled emulsion system instantly binds to glucose molecules and reduces the hydrogen bonds of the PVPBA homopolymer, resulting in insulin release. In a streptozotocin‐induced type 1 diabetic mouse model, a single subcutaneous injection of the gelled emulsion rapidly responds to high blood glucose concentration (BGC) and release insulin in a glucose dependent manner, thus prolonging the antihyperglycemic effect compared with free insulin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai, 200240, China.
- National Key Laboratory of Innovative Immunotherapy, Shanghai Jiao Tong University, Shanghai, 200240, China.
ORCID-Profile: Xue-Qing Zhang
Förderung
- The Natural Science Foundation of Shanghai
- The National Natural Science Foundation of China
Zitieren
APA
Boakye-Yiadom, K. O., Chen, Q., Teng, Y., Zhang, C., Hu, B., & Zhang, X. Q. (2024). Injectable Gelled Multiple Emulsion for Glucose‐Responsive Insulin Delivery. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202304195
Vancouver
Boakye-Yiadom KO, Chen Q, Teng Y, Zhang C, Hu B, Zhang XQ. Injectable Gelled Multiple Emulsion for Glucose‐Responsive Insulin Delivery. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202304195
BibTeX
@article{BoakyeYiadom2024,
author = {Boakye-Yiadom, Kofi Oti and Chen, Qijing and Teng, Yilong and Zhang, Chenshuang and Hu, Bin and Zhang, Xue-Qing},
title = {Injectable Gelled Multiple Emulsion for Glucose‐Responsive Insulin Delivery},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202304195}
}
EUVIMED